AstraZeneca Finds No Evidence Showing Increased Risk of Blood Clots With COVID-19 Vaccine

Vials labelled "AstraZeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo in this illustration, on March 10, 2021. Dado Ruvic/Reuters, Illustration/File Photo

AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.

The review covered more than 17 million people vaccinated in the European Union and United Kingdom.